1. 92P Neoadjuvant multimodality RX including immunotherapy for highly selective unresectable locally advanced esophageal squamous cell carcinoma (NEXUS): A prospective, single-arm, phase II trial. (December 2022) Authors: Wang, X.; Chen, X.; Kang, X.; Zhang, R.; Qu, D.; Xue, L.; Cheng, G.; Xi, G.; Zhang, T.; Deng, L.; Liu, W.; Bi, N.; Li, Y. Journal: Immuno-oncology technology Issue: Volume 16(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Physical activity and sedentary behaviour among children and adolescents with intellectual disabilities during the COVID‐19 lockdown in China. Issue 12 (3rd November 2021) Authors: Yuan, Y. Q.; Ding, J. N.; Bi, N.; Wang, M. J.; Zhou, S. C.; Wang, X. L.; Zhang, S. H.; Liu, Y.; Roswal, G. Other Names: Hilgenkamp Thessa guestEditor.; Oppewal Alyt guestEditor. Journal: Journal of intellectual disability research Issue: Volume 66:Issue 12(2022) Page Start: 913 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗